Featured Research

from universities, journals, and other organizations

Pharmaceutical industry support not desirable but frequently accepted by residency program directors

Date:
February 22, 2010
Source:
JAMA and Archives Journals
Summary:
Most directors of internal medicine residency training programs would prefer not to accept pharmaceutical support for the residencies they oversee, but more than half report doing so, according to a new article.

Most directors of internal medicine residency training programs would prefer not to accept pharmaceutical support for the residencies they oversee, but more than half report doing so, according to an article in the February 22 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

Related Articles


"Over the past two decades, the impact of pharmaceutical industry marketing on the professionalism and prescribing practices of physicians has gained national media attention," the authors write as background information in the article. Several professional organizations have issued guidelines for appropriate relationships between physicians and the industry. Because medical residents are at a particularly formative time in their career, separate guidelines were issued in 2002 by the Accreditation Council for Graduate Medical Education (ACGME).

"Despite such attention, a nationally representative description of the current landscape of pharmaceutical industry support to residency programs is not known," write Laura L. Loertscher, M.D., M.P.H., of Mayo Clinic, Rochester, Minn., and colleagues. To assess current attitudes and practices, the researchers analyzed data from a survey of 381 U.S. internal medicine residency program directors conducted in 2006 and 2007.

Of the 236 program directors (61.9 percent) who responded to the survey:

  • 170 (72 percent) expressed the opinion that pharmaceutical support is undesirable.
  • 132 (55.9 percent) reported accepting pharmaceutical industry support.
  • Those who accepted industry support did so in several common forms, including food for conferences (90.9 percent), educational materials (83.3 percent), office supplies (68.9 percent) and drug samples (57.6 percent).
  • Half reported that the final decision to accept industry support rested with them, whereas the other half named another final decisionmaker, such as a hospital administrator, chair of medicine or institutional oversight committee.
  • 153 (64.8 percent) worked at institutions that had established formal written guidelines, whereas 69 (29.2 percent) had implemented a specific curriculum to educate residents on these interactions.

The proportion of program directors accepting industry support was much lower among those who reported finding it unacceptable (22.7 percent) vs. those who found it desirable (72.7 percent) or not desirable but acceptable (71.2 percent). In addition, acceptance of pharmaceutical industry support appeared to be associated with a lower rate of program graduates passing the American Board of Internal Medicine (ABIM), one indicator of program quality.

"In addition to the important influence of program directors, residency program practices are likely affected by institutional history, available financial support and the culture within individual academic environments," the authors write. They also note that previous studies reported funding acceptance rates of 88.6 percent in 1990. "Although all of the underlying reasons are not yet fully elucidated, it is clear that, in the face of attention around conflict of interest with pharmaceutical support, internal medicine residency program directors have taken a less permissive stance and acceptance of industry funding has declined."


Story Source:

The above story is based on materials provided by JAMA and Archives Journals. Note: Materials may be edited for content and length.


Journal Reference:

  1. Laura L. Loertscher; Andrew J. Halvorsen; Brent W. Beasley; Eric S. Holmboe; Joseph C. Kolars; Furman S. McDonald. Pharmaceutical Industry Support and Residency Education: A Survey of Internal Medicine Program Directors. Arch Intern Med, 2010; 170 (4): 356-362 [link]

Cite This Page:

JAMA and Archives Journals. "Pharmaceutical industry support not desirable but frequently accepted by residency program directors." ScienceDaily. ScienceDaily, 22 February 2010. <www.sciencedaily.com/releases/2010/02/100222161854.htm>.
JAMA and Archives Journals. (2010, February 22). Pharmaceutical industry support not desirable but frequently accepted by residency program directors. ScienceDaily. Retrieved October 31, 2014 from www.sciencedaily.com/releases/2010/02/100222161854.htm
JAMA and Archives Journals. "Pharmaceutical industry support not desirable but frequently accepted by residency program directors." ScienceDaily. www.sciencedaily.com/releases/2010/02/100222161854.htm (accessed October 31, 2014).

Share This



More Health & Medicine News

Friday, October 31, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

U.S. Ebola Response Measures Demonstrated

U.S. Ebola Response Measures Demonstrated

AP (Oct. 31, 2014) Officials in the Washington area showed off Ebola response measures being taken at Dulles International Airport and the National Institutes of Health. (Oct. 31) Video provided by AP
Powered by NewsLook.com
Fauci Says Ebola Risk in US "essentially Zero"

Fauci Says Ebola Risk in US "essentially Zero"

AP (Oct. 30, 2014) NIAID Director Anthony Fauci said the risk of Ebola becoming an epidemic in the U.S. is essentially zero Thursday at the Washington Ideas Forum. He also said an Ebola vaccine will be tested in West Africa in the next few months. (Oct. 30) Video provided by AP
Powered by NewsLook.com
Nurse Defies Ebola Quarantine With Bike Ride

Nurse Defies Ebola Quarantine With Bike Ride

AP (Oct. 30, 2014) A nurse who vowed to defy Maine's voluntary quarantine for health care workers who treated Ebola patients followed through on her promise Thursday, leaving her home for an hour-long bike ride. (Oct. 30) Video provided by AP
Powered by NewsLook.com
Pot-Infused Edibles Raise Concerns in Colorado

Pot-Infused Edibles Raise Concerns in Colorado

AFP (Oct. 30, 2014) Colorado may have legalized marijuana for recreational use, but the debate around the decision still continues, with a recent - failed - attempt to ban cannabis-infused edibles. Duration: 01:53 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins